Stericycle (SRCL) Stock Price
Stericycle Price
Over the last 19 years Stericycle grew revenue by 9.0% annually, reaching 2.66 B USD. Earnings per share have declined at 2.0% per year over the last 18 years. For Stericycle, the net margin of -0.8% is up versus -10.5% a few years ago. The consensus 12-month price target for Stericycle is 63.24 USD, about 2.0% above where the stock trades today. Of 14 analysts, 6 rate the stock a buy — an overall Hold consensus.
Stericycle stock price
Details
Stock Price
ⓘHow to Read This Chart
This chart tracks the historical stock price of Stericycle over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.
Total Return vs. Price Return
The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.
Intraday Price Data
When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Stericycle stock reacts to market openings, earnings releases, or breaking news throughout the trading session.
What to Look For
Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Stericycle's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.
| Date | Stericycle Price |
|---|
Stericycle Revenue, EBIT, Net Income
3 Years
5 Years
10 Years
25 Years
Max
Details
Stericycle Income Statement, Balance Sheet, Cash Flow Statement
| REVENUEB USD |
|---|
| REVENUE GROWTH% |
| GROSS MARGIN% |
| GROSS INCOMEB USD |
| EBITM USD |
| EBIT MARGIN% |
| NET INCOMEM USD |
| NET INCOME GROWTH% |
| SHARESM |
| 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024e | 2025e | 2026e | 2027e | 2028e | 2029e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.56 | 2.99 | 3.56 | 3.58 | 3.49 | 3.31 | 2.68 | 2.65 | 2.70 | 2.66 | 2.72 | 2.81 | 2.96 | 3.10 | 3.24 | 3.45 |
| 19.28 | 16.83 | 19.33 | 0.51 | -2.65 | -5.08 | -19.14 | -1.08 | 2.19 | -1.66 | 2.33 | 3.20 | 5.56 | 4.69 | 4.42 | 6.51 |
| 42.82 | 40.40 | 42.20 | 40.84 | 39.48 | 35.49 | 39.36 | 38.44 | 37.91 | 34.15 | 34.15 | 34.15 | 34.15 | 34.15 | 34.15 | 34.15 |
| 1.09 | 1.21 | 1.50 | 1.46 | 1.38 | 1.17 | 1.05 | 1.02 | 1.03 | 0.91 | 0.93 | 0.96 | 1.01 | 1.06 | 1.11 | 1.18 |
| 556.00 | 487.00 | 439.00 | -7.00 | -169.00 | 109.00 | 149.00 | 72.00 | 180.00 | 77.00 | 313.00 | 87.00 | 93.00 | 97.00 | 102.00 | – |
| 21.76 | 16.31 | 12.32 | -0.20 | -4.85 | 3.30 | 5.57 | 2.72 | 6.66 | 2.90 | 11.50 | 3.10 | 3.14 | 3.13 | 3.15 | – |
| 326.00 | 267.00 | 205.00 | 42.00 | -244.00 | -346.00 | -55.00 | -26.00 | 56.00 | -21.00 | 210.00 | 259.00 | 324.00 | 388.00 | 413.00 | – |
| 4.82 | -18.10 | -23.22 | -79.51 | -680.95 | 41.80 | -84.10 | -52.73 | -315.38 | -137.50 | -1,100.00 | 23.33 | 25.10 | 19.75 | 6.44 | – |
| 86.19 | 85.95 | 85.43 | 85.60 | 90.70 | 91.20 | 91.80 | 91.90 | 92.50 | 92.80 | 92.80 | 92.80 | 92.80 | 92.80 | 92.80 | 92.80 |
Details
Income Statement Key Figures
ⓘRevenue and Revenue Growth
Revenue is the starting point of every income statement — it measures the total sales Stericycle generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.
Gross Margin
Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Stericycle retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Stericycle's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.
EBIT and EBIT Margin
EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.
Net Income and Earnings Per Share (EPS)
Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.
Shares Outstanding
The total number of shares Stericycle has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.
Analyst Estimates
The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Stericycle's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.
Stericycle stock margins
3 Years
5 Years
10 Years
25 Years
Max
Details
Stericycle Stock Revenue, EBIT, Earnings per Share
3 Years
5 Years
10 Years
25 Years
Max
Details
Stericycle business model & stock analysis
Stericycle SWOT Analysis
Strengths
Stericycle Inc has a strong reputation in the waste management industry, with over 30 years of experience. The company has established trust and credibility among its customers.
Stericycle Inc offers a comprehensive range of waste management services, including medical, pharmaceutical, and hazardous waste disposal. This allows the company to cater to various industries and meet diverse needs.
The company has a widespread network of facilities and a large fleet of vehicles, enabling efficient pickup, transportation, and disposal of waste materials.
Weaknesses
Stericycle Inc faces increasing competition in the waste management sector. The company needs to stay innovative and adapt to changing market trends to maintain its market share.
Some customers may perceive Stericycle Inc's services as costly compared to other waste management providers. This can potentially impact the company's ability to attract price-sensitive clients.
Inefficient waste management processes or delays could harm Stericycle Inc's reputation and result in customer dissatisfaction.
Opportunities
With the growing concern for environmental sustainability, Stericycle Inc can capitalize on the increasing demand for eco-friendly waste disposal methods. Developing and promoting green initiatives can lead to new business opportunities.
Expanding into emerging markets and partnering with healthcare organizations and pharmaceutical companies can create new revenue streams for Stericycle Inc.
Advancements in technology can be leveraged by Stericycle Inc to enhance operational efficiency, streamline waste management processes, and improve overall customer experience.
Threats
Changes in regulations related to waste management and disposal can pose a threat to Stericycle Inc's operations. Compliance with stringent regulatory requirements may increase costs and affect profitability.
Economic downturns or reduced healthcare spending can impact the demand for Stericycle Inc's services, as healthcare providers may look for ways to cut costs.
The emergence of new competitors or consolidation within the waste management industry can intensify competition and potentially erode Stericycle Inc's market share.
Stericycle Employees
3 Years
5 Years
10 Years
25 Years
Max
Details
Stericycle Segments
Stericycle Revenue by Segment (1/5)
3 Years
5 Years
10 Years
Max
Details
Stericycle Revenue by Segment (2/5)
3 Years
5 Years
10 Years
Max
Details
Stericycle Revenue by Segment (3/5)
3 Years
5 Years
10 Years
Max
Details
Stericycle Revenue by Segment (4/5)
3 Years
5 Years
Max
Details
Stericycle Revenue by Segment (5/5)
3 Years
5 Years
10 Years
Max
Details
Stericycle Revenue by Region
3 Years
5 Years
10 Years
Max
Details
Stericycle Eulerpool Fair Value
Details
Fair Value Estimate
ⓘWhat Is Fair Value?
Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.
Earnings-Based Fair Value
Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.
Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021
Revenue-Based Fair Value
Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"
Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021
Dividend-Based Fair Value
Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.
Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021
How to Use This Chart
When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.
Stericycle historical P/E ratio, EBIT multiple, and P/S ratio
Stericycle annual returns
Details
Annual Return
ⓘWhat This Chart Shows
This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.
Price Return
Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.
Dividend Return
Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.
What to Look For
Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.
Stericycle shares outstanding
3 Years
5 Years
10 Years
25 Years
Max
Details
Stericycle stock splits
Current Stericycle forecasts and price targets in August 2026
Analyst Price Targets 2026Stericycle Analyst Rating Actions
| Date | Firm | Action | Rating | Reliability |
|---|---|---|---|---|
| 6/4/2024 | Maintained | Hold | – | |
| 6/4/2024 | Downgrade | OutperformSector Perform | 52 | |
| 6/4/2024 | Maintained | Outperform | – | |
| 4/29/2024 | Maintained | Hold | – | |
| 4/26/2024 | Maintained | Neutral | – | |
| 3/7/2024 | Maintained | Outperform | 52 | |
| 3/1/2024 | Maintained | Underweight | 56 | |
| 2/29/2024 | Maintained | Hold | – | |
| 2/29/2024 | Maintained | Buy | – | |
| 2/29/2024 | Maintained | Outperform | 52 |
Eulerpool Reliability Score (0–100): measures how often a firm’s bullish or bearish calls were directionally correct three months later, blended with the average return following its calls. Every rating we record is stored permanently and scores update continuously; firms with fewer than 3 measured calls are not scored yet.
Stericycle Earnings Estimates & Surprises
| Date | EPS estimate | EPS Actual | Revenue Estimate | Price reaction | Quarterly report |
|---|---|---|---|---|---|
| 4/25/2024 | 0.49USD | - | 683.74 MUSD | - | 2024 Q1 |
| 2/21/2024 | 0.48USD | - | 670.63 MUSD | - | 2023 Q4 |
| 8/3/2023 | 0.58USD | - | 712.12 MUSD | - | 2023 Q2 |
| 4/26/2023 | 0.55USD | - | 700.65 MUSD | - | 2023 Q1 |
| 2/22/2023 | 0.62USD | - | 711.47 MUSD | - | 2022 Q4 |
| 11/3/2022 | 0.59USD | - | 685.34 MUSD | - | 2022 Q3 |
| 8/5/2022 | 0.49USD | - | 687.30 MUSD | - | 2022 Q2 |
| 4/28/2022 | 0.47USD | - | 681.07 MUSD | - | 2022 Q1 |
| 2/24/2022 | 0.48USD | - | 669.73 MUSD | - | 2021 Q4 |
| 11/2/2021 | 0.61USD | - | 680.30 MUSD | - | 2021 Q3 |
EESG©
Eulerpool ESG Scorecard© for the Stericycle stock
EEnvironment
20
Environment
SSocial
20
Social
GGovernance (Corporate Governance)
4
Governance (Corporate Governance)
The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.
Stericycle shareholder structure
| % | Name |
|---|---|
0.27948% | |
0.27241% | |
0.26934% | |
0.12868% | |
0.09999% | |
0.08268% |
Stericycle Beneficial Ownership Filings (SEC 13D/G)
| Stake | Holder | Filing |
|---|---|---|
11.00% | SEC ↗ | |
9.10% | SEC ↗ | |
8.20% | SEC ↗ | |
7.40% | SEC ↗ | |
7.20% | SEC ↗ | |
7.20% | SEC ↗ | |
7.00% | SEC ↗ | |
6.90% | SEC ↗ | |
6.51% | SEC ↗ | |
6.51% | SEC ↗ |
Stericycle Executives and Management Board
12 members · avg. age 62 · 8 % women
Mr. Joseph Reuter (62)
Executive Vice President, Chief People Officer
937,999.00 USD
Mr. Michael Weisman (65)
Executive Vice President, Chief Ethics and Compliance Officer
Mr. Dominic Culotta (60)
Executive Vice President, Chief Engineer and Chief Transformation Officer
Mr. Richard Moore (62)
Executive Vice President - North American Operations
Mr. Rafael Carrasco
Executive Officer, Director · since 2024
Mr. Courtney Tippy
Executive Officer, Director · since 2024
Mr. Jeff Bennett
Executive Officer
Stericycle Supply Chain
Stericycle Supply Chain
Correlation: how closely stock prices move together
| # | Name | Trend | |||
|---|---|---|---|---|---|
| 1 | 0.76 | 0.91 | 0.63 | ||
| 2 | 0.76 | 0.94 | 0.60 |
| # | Name | Trend | |||
|---|---|---|---|---|---|
| 1 | -0.55 | -0.86 | -0.73 | ||
| 2 | -0.60 | -0.41 | -0.14 |
Frequently asked questions about Stericycle
Stericycle Inc's business model revolves around providing comprehensive solutions for managing regulated waste and providing secure information destruction services. As a leading provider in the industry, Stericycle offers a range of services, including medical waste disposal, hazardous waste management, shredding, and compliance training. By focusing on helping businesses and healthcare organizations comply with stringent regulations, Stericycle ensures the safety and protection of employees, patients, and the environment. With its innovative solutions and commitment to quality, Stericycle Inc has established itself as a trusted partner in waste management and secure information destruction.
Stericycle Inc is primarily active in the waste management industry.
The main competitors of Stericycle Inc in the market include Waste Management Inc, Republic Services Inc, and Clean Harbors Inc.
Stericycle Inc, based in Lake Forest, Illinois, is a leading provider of regulated medical waste management and secure information destruction services. Founded in 1989 by Mark C. Miller, Stericycle initially focused on collecting and treating medical waste from healthcare facilities. Over the years, the company expanded its services to include hazardous waste disposal, pharmaceutical returns, product recalls, and compliance training. Stericycle has grown through strategic acquisitions and now serves customers in the healthcare, retail, and industrial sectors worldwide. This global presence and diversified service portfolio have established Stericycle as a trusted and reliable partner for managing complex waste and compliance needs.
Stericycle Inc, a leading medical waste management company, has achieved significant milestones since its inception. The company expanded its services globally, delivering comprehensive solutions for healthcare waste management, compliance, and secure data destruction. Stericycle Inc successfully established itself as a trusted partner in the healthcare industry, offering safe and environmentally-friendly disposal solutions while ensuring regulatory compliance. The company's dedication to innovation resulted in groundbreaking technologies, such as the Steri-Smart™ System, streamlining waste collection and disposal processes for healthcare facilities. Stericycle Inc's commitment to customer satisfaction and continuous improvement has contributed to its growth, making it a noteworthy player in the industry.
Stericycle Inc is primarily present in multiple countries and regions across the globe. The company operates and serves customers in the United States, Canada, Mexico, Argentina, Brazil, Chile, Colombia, Costa Rica, Puerto Rico, Peru, India, Ireland, Spain, Portugal, Germany, Austria, Belgium, Denmark, Finland, France, Italy, Netherlands, Norway, Poland, Sweden, Switzerland, United Kingdom, Australia, New Zealand, Hong Kong, Japan, Malaysia, Singapore, South Korea, Taiwan, and Thailand. With a wide geographic presence, Stericycle Inc offers its comprehensive services and solutions to numerous markets worldwide.
Stericycle Inc embodies a strong set of values and corporate philosophy. The company is committed to providing safe, sustainable, and compliant solutions for managing regulated waste and protecting the environment. With a focus on integrity, accountability, and customer satisfaction, Stericycle aims to be the preferred partner in healthcare, pharmaceutical, and retail industries. They prioritize employee safety, diversity, and community engagement, fostering a positive and inclusive work environment. By continuously innovating and adhering to strict ethical standards, Stericycle demonstrates its dedication to delivering exceptional waste management services while upholding its commitment to social responsibility and sustainability.
Analysts currently set an average price target of 63.01 USD for the Stericycle stock (median: 63.24 USD), implying +1.7 % versus the latest price. The consensus is based on 14 analyst ratings.
14 analysts currently rate the Stericycle stock: 6 recommend buying, 8 holding and 0 selling. For 2026, analysts expect Stericycle to generate revenue of 2.96 B USD and earnings per share of 3.50 USD.
Converted at the current exchange rate, the Stericycle share trades at 53.75 EUR (61.98 USD).
The Stericycle share (SRCL) is listed on 7 stock exchanges, including: NASDAQ (SRCL), Frankfurt (SY9.F), München (SY9.MU), Düsseldorf (SY9.DU), Hamburg (SY9.HM), London (0L9O.L), SIX (Zürich) (SRCL.SW).
Stericycle Inc is a provider of waste disposal and compliance solutions in the fields of health and environment. The company offers its services to various industries, including healthcare, life sciences, retail, government, education, and manufacturing. 1. Regulated medical disposal: Stericycle is a leading provider of medical disposal services for hospitals, doctor's offices, labs, and other facilities that produce healthcare-related waste. The company offers options for waste collection, transportation, treatment, and destruction. 2. Compliance solutions: Stericycle helps companies comply with regulations and guidelines in the fields of health and environment. The company offers training, consulting, practice review, and the provision of informational materials. 3. Communication and marketing solutions: Stericycle provides support to companies in developing, designing, and delivering marketing and customer communication content. The company's services include printing and mailing services, email management, and online tools. 4. Recall and retrieval solutions: Stericycle offers services for the retrieval of products that are defective or dangerous. The company works with customers to plan and coordinate the recall process, and also provides retrieval solutions to recover the products. In addition to these four main divisions, Stericycle also offers a wide range of products and services, including medical maintenance packages, specialized waste bins and containers, medical equipment, as well as safety and compliance products. Stericycle's business model is based on providing solutions to companies that deal with waste disposal and compliance in the fields of health and environment. Stericycle offers comprehensive services that enable customers to comply with legal requirements, safely dispose of waste, and minimize risks to public health and the environment. Stericycle aims to develop innovative services and solutions to meet the changing needs of its customers. The company invests in new technologies and acquires companies to expand its services and improve its offerings. Overall, Stericycle's business model is aligned with the needs and priorities of its customers. By providing reliable, secure, and comprehensive solutions, the company has established a strong position in the waste disposal and compliance solutions industry.
The expected revenue of Stericycle is 2.96 B USD. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Stericycle is 324.94 M USD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Stericycle is currently 17.70. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Stericycle stock.
The price-to-sales ratio (P/S) of Stericycle is currently 1.94. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Stericycle stock.
The Eulerpool Quality Score for Stericycle is 0/10.
The ISIN of Stericycle is US8589121081. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of Stericycle is 902518. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of Stericycle is SRCL. The ticker symbol is used to trade Stericycle shares on the stock exchange.
Stericycle paid dividends every year for the past 0 years.
Stericycle is assigned to the 'Industry' sector.
The dividends of Stericycle are distributed in USD.
Stericycle stock
Stericycle Peer Group
Stericycle Ticker
Stericycle FIGI
All fundamentals and in-depth analysis of Stericycle
Our stock analysis for Stericycle stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Stericycle. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.